Video

Jerry Bagel, MD, Explains How to Measure Success in Psoriasis Treatment

Author(s):

As patients go through the process of treating their plaque psoriasis, there can be different levels of success depending on a number of situations. As a result, measuring success can be a challenge as well.

As patients go through the process of treating their plaque psoriasis there can be different levels of success depending on a number of situations. As a result, measuring success can be a challenge as well.

Jerry Bagel, MD, of the Psoriasis Treatment Center of Central New Jersey, said that as patients go through the process of treating their plaque psoriasis there can be different levels of success depending on a number of situations.

Particularly, patients that do 90% better, tend to stay 90% better, but those who only are 75% better, “it seems to wear off over time,” he said.

In addition, the percent of body surface area with psoriasis, such as less than 2%, can have an impact on patient satisfaction or anxiety. As a result of these factors, measuring success can be a challenge as well.

Related Videos
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
© 2024 MJH Life Sciences

All rights reserved.